General Corporate
Company information, general questions, website matters, and corporate communications.
Contact GenBio
Begin a Conversation with GenBio.
Contact GenBio regarding corporate information, scientific or strategic opportunities, investor inquiries, approved publications, or other appropriate matters.
Inquiry Routing
Direct Your Message to the Appropriate Area.
Please select the inquiry type that most closely matches your reason for contacting GenBio. Submission of an inquiry does not create an obligation to respond, disclose information, enter discussions, or proceed with a proposed opportunity.
Scientific and Strategic
Research capabilities, scientific opportunities, collaboration, and strategic engagement.
Investor and Transaction
Qualified corporate, investor, diligence, or transaction-related inquiries.
Media and Publications
Approved company information, media requests, publications, and newsroom-related matters.
Send an Inquiry
Contact GenBio
Complete the form below. Do not submit confidential, proprietary, privileged, patient-identifiable, or otherwise sensitive information through this form.
What to Expect
Inquiries Are Reviewed According to Their Purpose and Relevance.
-
01
Submission
Your message is delivered through GenBio’s approved corporate communication channel.
-
02
Internal Routing
The inquiry may be routed according to its corporate, scientific, investor, or communications purpose.
-
03
Initial Review
GenBio determines whether a response, referral, qualification step, or additional discussion is appropriate.
-
04
Appropriate Follow-Up
Further communication may occur where the inquiry aligns with GenBio’s interests and review requirements.
Important Notice
Public Contact Does Not Authorize Confidential Disclosure.
Do not submit confidential scientific information, intellectual property, trade secrets, personal health information, privileged material, or other sensitive information through the public contact form.
Submission of an inquiry does not create a confidential, advisory, fiduciary, partnership, licensing, investment, employment, or other formal relationship.
Any exchange of non-public information remains subject to appropriate qualification, review, authorization, confidentiality protections, and documentation.